Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 3 9Phase 1 5Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Head and Neck Neoplasms 4Small Cell Lung Carcinoma 3Lymphoma, Extranodal NK-T-Cell 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Non-small-cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Non-Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Locally Advanced Malignant Neoplasm 1Intracranial Germ Cell Tumors 1Carcinoma, Squamous Cell 1Cancer Therapy-related Cardiovascular Toxicity 1Biliary Tract Neoplasms 1Anemia 1Adenocarcinoma of Lung 1

Interventions

Pemetrexed 2endostar protein 1Erlotinib Hydrochloride 1Endostatins 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Adenocarcinoma of Lung × Cisplatin × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡